Zai Lab Ltd
NASDAQ:ZLAB
Zai Lab Ltd
NASDAQ:ZLAB
Price:
19.015
USD
-2.74%
Market Closed
Market Cap:
$1.9B
Balance Sheet
Balance Sheet Decomposition
Zai Lab Ltd
Zai Lab Ltd
Balance Sheet Decomposition is not available for
Zai Lab Ltd
Zai Lab Ltd
Balance Sheet
Zai Lab Ltd
Zai Lab Ltd
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
230
|
63
|
76
|
442
|
964
|
1 008
|
790
|
450
|
|
| Cash |
204
|
37
|
75
|
441
|
664
|
1 007
|
789
|
449
|
|
| Cash Equivalents |
26
|
26
|
1
|
1
|
301
|
1
|
1
|
1
|
|
| Short-Term Investments |
0
|
200
|
200
|
745
|
445
|
0
|
16
|
330
|
|
| Total Receivables |
0
|
0
|
4
|
5
|
55
|
49
|
65
|
89
|
|
| Accounts Receivables |
0
|
0
|
4
|
5
|
48
|
40
|
59
|
85
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
7
|
9
|
6
|
4
|
|
| Inventory |
0
|
0
|
6
|
13
|
19
|
32
|
45
|
40
|
|
| Other Current Assets |
1
|
6
|
7
|
11
|
18
|
36
|
23
|
142
|
|
| Total Current Assets |
231
|
269
|
293
|
1 216
|
1 501
|
1 124
|
940
|
1 050
|
|
| PP&E Net |
12
|
21
|
36
|
47
|
57
|
77
|
69
|
69
|
|
| PP&E Gross |
12
|
21
|
36
|
47
|
57
|
77
|
69
|
69
|
|
| Accumulated Depreciation |
1
|
2
|
6
|
10
|
16
|
22
|
30
|
37
|
|
| Intangible Assets |
0
|
0
|
9
|
9
|
10
|
8
|
16
|
59
|
|
| Note Receivable |
5
|
8
|
14
|
22
|
24
|
0
|
0
|
1
|
|
| Long-Term Investments |
2
|
3
|
2
|
1
|
16
|
6
|
9
|
3
|
|
| Other Long-Term Assets |
0
|
1
|
1
|
2
|
3
|
4
|
2
|
2
|
|
| Total Assets |
250
N/A
|
302
+21%
|
355
+18%
|
1 298
+265%
|
1 610
+24%
|
1 220
-24%
|
1 036
-15%
|
1 186
+14%
|
|
| Liabilities | |||||||||
| Accounts Payable |
9
|
37
|
23
|
63
|
126
|
66
|
113
|
101
|
|
| Accrued Liabilities |
2
|
4
|
14
|
19
|
32
|
51
|
65
|
55
|
|
| Short-Term Debt |
0
|
4
|
7
|
0
|
0
|
0
|
0
|
132
|
|
| Other Current Liabilities |
2
|
4
|
4
|
17
|
35
|
23
|
25
|
12
|
|
| Total Current Liabilities |
12
|
49
|
47
|
98
|
193
|
140
|
203
|
299
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
2
|
2
|
14
|
30
|
37
|
35
|
37
|
45
|
|
| Total Liabilities |
15
N/A
|
51
+251%
|
61
+19%
|
128
+112%
|
230
+79%
|
175
-24%
|
240
+38%
|
345
+44%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
111
|
250
|
445
|
714
|
1 418
|
1 861
|
2 196
|
2 453
|
|
| Additional Paid In Capital |
345
|
498
|
735
|
1 898
|
2 826
|
2 893
|
2 975
|
3 264
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
4
|
12
|
21
|
21
|
|
| Other Equity |
0
|
3
|
5
|
15
|
24
|
26
|
38
|
51
|
|
| Total Equity |
235
N/A
|
251
+7%
|
295
+17%
|
1 169
+297%
|
1 380
+18%
|
1 046
-24%
|
796
-24%
|
841
+6%
|
|
| Total Liabilities & Equity |
250
N/A
|
302
+21%
|
355
+18%
|
1 298
+265%
|
1 610
+24%
|
1 220
-24%
|
1 036
-15%
|
1 186
+14%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
499
|
499
|
682
|
878
|
955
|
960
|
972
|
1 078
|
|
Switch to:
Switch to:
See Also
Discover More
